#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucopolysaccharidosis I Pemphigus Von Willebrand's disease Malignant fibrous histiocytoma Carcinoid syndrome Chronic cutaneous lupus erythematosus T-cell lymphoma Acute lymphocytic leukaemia recurrent HER2 gene amplification Chondrosarcoma metastatic Gaucher's disease type I Hyperchylomicronaemia Ehlers-Danlos syndrome Tuberous sclerosis complex Porphyria non-acute More trials…

    Learn about Rare Diseases

    Propionic acidaemia – Treatment Prolymphocytic leukaemia – Life with Disease Ehlers-Danlos syndrome – Trials in Disease Vascular malformation – Trials in Disease Mastocytosis – Diagnostics Waldenstrom’s macroglobulinaemia – Diagnostics CADASIL – Diagnostics Lymphatic malformation – Treatment Richter’s syndrome – Trials in Disease Immunodeficiency congenital – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Evg321 Blood And Related Products Benzathine Benzylpenicillin SULBACTAM SODIUM Saxagliptin Vericiguat Fostemsavir Enmetazobactam Human Coagulation Factor Ii Bilastine Pamiparib Mycophenolate Sodium Methoxyflurane Ustekinumab Donepezil Flutafuranol (18F) Bosutinib Odronextamab Gozetotide Dicloxacillin More therapies…

    Learn about Your Condition

    Urinary tract infection Ocular melanoma Lichenoid keratosis Sarcoidosis Muscle spasticity Malignant melanoma of eyelid Oesophageal adenocarcinoma Prostatitis Escherichia coli Bacterial prostatitis Renal cancer recurrent Osteonecrosis of jaw Biopsy heart Tuberculosis Myopia Gaucher's disease type I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on the Effectiveness and Tolerability of Oral vs. Subcutaneous Methotrexate for Patients with Early Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Methotrexate
    Sweden

  • Study of Diclofenac compared to Placebo for Pain Relief in Adults with Knee Osteoarthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Diclofenac Sodium
    Denmark

  • Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    Austria Belgium Bulgaria Croatia Czechia Estonia +14

  • Study on Gout Treatment: Comparing Allopurinol, Benzbromarone, and Febuxostat in Patients with Gout in Remission

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Gouty arthritis
    • Gout
    Investigated Drugs:
    • Allopurinol
    • Febuxostat Hemihydrate
    The Netherlands

  • Study of DYNE-251 safety and effectiveness in patients with Duchenne muscular dystrophy who are candidates for exon 51 skipping treatment

    Not recruiting

    2 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Fragment Antibody Targeting Human Tfr1 Conjugated To Phosphorodiamidate Morpholino Oligomer
    Belgium Ireland Italy Spain

  • Study of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History

    Not recruiting

    3 1
    Investigated Diseases:
    • Spinal muscular atrophy
    Investigated Drugs:
    • Taldefgrobep Alfa
    Belgium Czechia Germany Italy The Netherlands Poland +1
Previous Page
1 … 57 58 59 60 61 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!